Study reveals shortcomings of drug-vial warning labels
GlaxoSmithKline to revise alli label as FDA completes safety review of orlistat
Low-profile tube: Product of the Day
Packaging design: Bausch + Lomb introduces new bottle design
Consumers ignore pharma risk warnings
Support grows for increased FDA authority to protect pharma supply chain